Annual CFI
-$206.60 K
+$4.66 M+95.75%
December 31, 2023
Summary
- As of February 7, 2025, KRBP annual cash flow from investing activities is -$206.60 thousand, with the most recent change of +$4.66 million (+95.75%) on December 31, 2023.
- During the last 3 years, KRBP annual CFI has risen by +$1.25 million (+85.83%).
- KRBP annual CFI is now -50.47% below its all-time high of -$137.30 thousand, reached on December 31, 2018.
Performance
KRBP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$219.00 K
-$121.00 K-123.47%
September 30, 2024
Summary
- As of February 7, 2025, KRBP quarterly cash flow from investing activities is -$219.00 thousand, with the most recent change of -$121.00 thousand (-123.47%) on September 30, 2024.
- Over the past year, KRBP quarterly CFI has dropped by -$121.00 thousand (-123.47%).
- KRBP quarterly CFI is now -265.41% below its all-time high of $132.40 thousand, reached on September 30, 2022.
Performance
KRBP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$446.60 K
-$121.00 K-37.16%
September 30, 2024
Summary
- As of February 7, 2025, KRBP TTM cash flow from investing activities is -$446.60 thousand, with the most recent change of -$121.00 thousand (-37.16%) on September 30, 2024.
- Over the past year, KRBP TTM CFI has dropped by -$121.00 thousand (-37.16%).
- KRBP TTM CFI is now -595.12% below its all-time high of $90.20 thousand, reached on June 30, 2023.
Performance
KRBP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
KRBP Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +95.8% | -123.5% | -37.2% |
| 3 y3 years | +85.8% | -100.0% | -595.1% |
| 5 y5 years | -50.5% | -100.0% | -595.1% |
KRBP Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +95.8% | -265.4% | +91.2% | -595.1% | +92.8% |
| 5 y | 5-year | at high | +95.8% | -265.4% | +91.2% | -595.1% | +92.8% |
| alltime | all time | -50.5% | +95.8% | -265.4% | +91.2% | -595.1% | +92.8% |
Kiromic BioPharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$219.00 K(+123.5%) | -$446.60 K(+37.2%) |
| Jun 2024 | - | -$98.00 K(+366.7%) | -$325.60 K(+43.1%) |
| Mar 2024 | - | -$21.00 K(-80.7%) | -$227.60 K(+10.2%) |
| Dec 2023 | -$206.60 K(-95.8%) | -$108.60 K(+10.8%) | -$206.60 K(+47.4%) |
| Sep 2023 | - | -$98.00 K(<-9900.0%) | -$140.20 K(-255.4%) |
| Jun 2023 | - | $0.00(0.0%) | $90.20 K(-103.8%) |
| Mar 2023 | - | $0.00(-100.0%) | -$2.38 M(-51.0%) |
| Dec 2022 | -$4.87 M(+168.7%) | -$42.20 K(-131.9%) | -$4.87 M(-17.8%) |
| Sep 2022 | - | $132.40 K(-105.4%) | -$5.92 M(-4.1%) |
| Jun 2022 | - | -$2.47 M(-0.4%) | -$6.18 M(+45.3%) |
| Mar 2022 | - | -$2.48 M(+126.3%) | -$4.25 M(+134.7%) |
| Dec 2021 | -$1.81 M | -$1.10 M(+792.8%) | -$1.81 M(+56.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$122.90 K(-77.5%) | -$1.16 M(-9.9%) |
| Jun 2021 | - | -$545.90 K(+1121.3%) | -$1.29 M(+17.3%) |
| Mar 2021 | - | -$44.70 K(-89.9%) | -$1.10 M(-24.8%) |
| Dec 2020 | -$1.46 M(+381.5%) | -$444.50 K(+77.2%) | -$1.46 M(+13.1%) |
| Sep 2020 | - | -$250.80 K(-29.6%) | -$1.29 M(+23.4%) |
| Jun 2020 | - | -$356.00 K(-12.4%) | -$1.04 M(+51.7%) |
| Mar 2020 | - | -$406.30 K(+47.1%) | -$689.00 K(+127.6%) |
| Dec 2019 | -$302.70 K(+120.5%) | -$276.20 K(+4149.2%) | -$302.70 K(+1042.3%) |
| Sep 2019 | - | -$6500.00(<-9900.0%) | -$26.50 K(+32.5%) |
| Jun 2019 | - | $0.00(-100.0%) | -$20.00 K(0.0%) |
| Mar 2019 | - | -$20.00 K | -$20.00 K |
| Dec 2018 | -$137.30 K | - | - |
FAQ
- What is Kiromic BioPharma annual cash flow from investing activities?
- What is the all time high annual CFI for Kiromic BioPharma?
- What is Kiromic BioPharma annual CFI year-on-year change?
- What is Kiromic BioPharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly CFI year-on-year change?
- What is Kiromic BioPharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kiromic BioPharma?
- What is Kiromic BioPharma TTM CFI year-on-year change?
What is Kiromic BioPharma annual cash flow from investing activities?
The current annual CFI of KRBP is -$206.60 K
What is the all time high annual CFI for Kiromic BioPharma?
Kiromic BioPharma all-time high annual cash flow from investing activities is -$137.30 K
What is Kiromic BioPharma annual CFI year-on-year change?
Over the past year, KRBP annual cash flow from investing activities has changed by +$4.66 M (+95.75%)
What is Kiromic BioPharma quarterly cash flow from investing activities?
The current quarterly CFI of KRBP is -$219.00 K
What is the all time high quarterly CFI for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly cash flow from investing activities is $132.40 K
What is Kiromic BioPharma quarterly CFI year-on-year change?
Over the past year, KRBP quarterly cash flow from investing activities has changed by -$121.00 K (-123.47%)
What is Kiromic BioPharma TTM cash flow from investing activities?
The current TTM CFI of KRBP is -$446.60 K
What is the all time high TTM CFI for Kiromic BioPharma?
Kiromic BioPharma all-time high TTM cash flow from investing activities is $90.20 K
What is Kiromic BioPharma TTM CFI year-on-year change?
Over the past year, KRBP TTM cash flow from investing activities has changed by -$121.00 K (-37.16%)